User banner image
User avatar
  • admin

Posts

/C O R R E C T I O N — SenseTime/

In the news release, DTGO partners with leading AI software company SenseTime to launch “DTLM”, a new trilingual LLM for Thai, Chinese, and English, issued...

Natural Tea Extract Market to Advance at a CAGR of 7.5% through 2034 Amid Expanding Usage in Functional Foods and Dietary Supplements | Future Market Insights, Inc.

The United States Natural Tea Extract industry is projected to grow at a CAGR of 7.8% from 2023 to 2033, maintaining its dominant market position....

Global Non-invasive Aesthetic Treatment Market Analysis Report 2024-2032 Featuring Johnson & Johnson, Bausch, Cutera, AbbVie, Sisram Medical, Galderma, Sientra, and Revance Therapeutics

Dublin, July 09, 2024 (GLOBE NEWSWIRE) — The “Non-invasive Aesthetic Treatment Market Report by Procedure, Injectables, Skin Rejuvenation, Others, Gender, End User, Country and Company...

Questex’s International Beauty Show and International Esthetics, Cosmetics and Spa Conference Premiered Co-Located Events in New West Hall of Las Vegas Convention Center

Shows Will Return to West Hall June 21-23, 2025 NEW YORK, July 09, 2024 (GLOBE NEWSWIRE) — Beauty and spa professionals converged at the new...

Sing Out Loud Festival Returns to Florida’s Historic Coast September 13-29

St. Augustine’s “Month of Music” features an array of performances throughout the city and Ponte Vedra St. Augustine, FL, July 09, 2024 (GLOBE NEWSWIRE) —...

Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results

Second quarter 2024 total revenue is in the range of $9.4 to $9.6 million Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., July...

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age

ZORYVE cream provides rapid relief, with efficacy, safety, and tolerability demonstrated up to 56 weeks of treatment ZORYVE cream rapidly and significantly reduces itch, the...

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) — Certara,...

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LAKE FOREST, Ill., July 09, 2024 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities...